Southwood Research

What Southwood Research does

ProPharma, legally ProPharma Group MIS Limited, is a privately held life sciences consulting firm founded in 1999 and registered in England and Wales. The company delivers an end-to-end suite of bespoke professional services across the full product lifecycle for pharmaceutical, biotechnology, and medical device organizations, including cell and gene therapy sponsors. Its service portfolio is organized around six pillars: Regulatory Sciences (FDA and EMA consulting, Marketing Authorization Holder partnerships, regulatory operations, global medical writing, advertising/promotional review), CRO Services (full-service clinical development, biostatistics, site and patient services), Quality and Compliance (GxP auditing, computer system validation, inspection readiness, QA/AI and ML compliance), Pharmacovigilance (clinical and post-marketing safety, signal management, QPPV, global submissions), Medical Information (24/7/365 global contact centers, adverse event intake, REMS/RMP support), FSP Solutions (embedded functional service provider teams), and Digital Transformation.

The firm operates a professional services revenue model with quote-based, customized pricing — no standard rate cards are published. Go-to-market is direct enterprise sales with dedicated program managers and asset strategists, targeting pharmaceutical, biotechnology, and medical device clients across primary, vertical segments. Customer concentration is not disclosed but the segmentation strategy suggests deliberate diversification across drug, biologic, device, diagnostic, animal health, and consumer health sponsors. Technologically, the platform rests on domain-specialized regulatory and clinical expertise with embedded AI/ML applications in medical information delivery and dedicated QA/AI compliance advisory for clients. The company maintains SBTi-validated net-zero targets, indicating formal ESG commitments. Awards in 2024 (CPHI Regulatory and Compliance, ECCCSA AI Excellence Silver, Clinical Trials Excellence) provide third-party validation of capability claims.

Name

Southwood Research

Legal name

ProPharma Group MIS Limited

Website

https://southwoodresearch.com

Company type

Private

Founded year

1999

Operating status

Operating

Short description

ProPharma is a privately held life sciences consulting firm offering end-to-end regulatory, CRO, quality/compliance, pharmacovigilance, medical information, FSP, and digital transformation services to pharmaceutical, biotechnology, and medical device companies globally.

Ownership category

akta.pro rank

Product category

Life Sciences Regulatory Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417), Management Consulting Services (54161)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO)

akta.pro secondary industries

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)

Keywords

• Regulatory consulting
• Clinical research services
• Pharmacovigilance services
• Medical information services
• Life sciences consulting

Headquarters

HQ city

Beaconsfield

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Professional Services - Regulatory Sciences: Consulting services for regulatory sciences including FDA regulatory consulting, European regulatory development, marketing authorization holder partnership, regulatory operations, and global medical writing
2. CRO Services: Full-service contract research organization services including site and patient services, biostatistics and programming, and medical device clinical services
3. Quality and Compliance Services: GxP compliance and auditing, computer system validation, QA/AI and ML compliance services, inspection readiness, clinical quality assurance, and digital transformation
4. Pharmacovigilance Services: Clinical and post-marketing pharmacovigilance, safety systems, QPPV and LPPV services, case management, signal management, and global submissions
5. Medical Information Services: Comprehensive medical information including 24/7/365 contact centers, adverse event intake, patient support, commercial services, and REMS and RMP support
6. FSP Solutions: Functional service provider solutions as extension of internal teams including clinical operations, data sciences, biostatistics, medical writing, and decentralized clinical trials

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Southwood Research provides an end-to-end suite of bespoke life sciences consulting services across the full product lifecycle, including Regulatory Sciences (FDA/EMA pre- and post-approval support for drugs, biologics, medical devices, and diagnostics), full-service CRO capabilities for multi-phase clinical development, Quality & Compliance (GxP auditing, computer system validation, inspection readiness), Pharmacovigilance Solutions (clinical and post-marketing safety), Medical Information Services (24/7/365 contact centers, adverse event intake), Functional Service Provider (FSP) staffing solutions, and Digital Transformation services. Services are delivered to biotech, pharmaceutical, and medical device organizations globally through a partnership-driven model with dedicated program managers and asset strategists.

Product overview

ProPharma is a comprehensive life sciences consulting organization offering an end-to-end suite of bespoke services across the full product lifecycle. The core portfolio includes Regulatory Sciences (FDA/EMA support, expert witness, lifecycle management), CRO Services (full-service clinical development), Quality & Compliance (GxP auditing, CSV, inspection readiness), Pharmacovigilance Solutions (post-marketing safety, signal management), Medical Information (24/7 contact centers, adverse event intake), FSP Solutions (flexible staffing), and Digital Transformation (technology enablement). Services span therapeutic areas including oncology, cardiovascular, CNS, infectious diseases, cell and gene therapy, and rare diseases.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Sciences Pre- and post-approval regulatory support for the FDA, EMA, and other national competent authorities covering drugs, biologics, medical devices, and diagnostics. Includes FDA regulatory consulting, European regulatory development, marketing authorization holder partnership, regulatory operations, global medical writing, advertising & promotional review, market access & reimbursement strategy, nonclinical development, and medical device regulatory solutions.
• CRO Services Full-service Contract Research Organization capabilities with a global team for multi-phase clinical development and study execution focused on drugs, biologics, medical devices, and diagnostics. Includes full-service CRO, site and patient services, global medical writing and transparency, biostatistics and programming, and medical device clinical services.
• Quality & Compliance Quality and compliance services including pharma consulting, regulation, GxP compliance and auditing, computer system validation (CSV), QA/AI & ML compliance services, inspection readiness, clinical quality assurance, commissioning/qualification/validation, program and project management, cell and gene therapy consulting, and healthcare compliance services.
• Pharmacovigilance Solutions Full suite of pharmacovigilance solutions ensuring safety and consistency from clinical development through post-approval, including clinical pharmacovigilance, post-marketing pharmacovigilance, safety systems, QPPV and LPPV services, case management, global literature review, signal management, periodic safety reports and risk management plans, global submissions, and regulatory intelligence.
• Medical Information Comprehensive medical information services including 24/7/365 integrated global contact centers, medical information delivery, adverse event intake and follow-up, product complaint intake and follow-up, patient support and commercial services, medical communications/content management/translation, animal health services, REMS & RMP support, and consumer health services.
• FSP Solutions Flexible Functional Service Provider staffing solutions that operate as an extension of internal client teams, providing top-tier professionals and proven processes across clinical operations, data sciences, biostatistics, medical writing and quality control, and decentralized clinical trials.
• Digital Transformation Technology solutions enabling life science organizations to get products to market quickly and efficiently, including digital blueprint development, data strategy consulting, technology services, and validation/quality/compliance for digital transformation initiatives.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• ICON plc: Major global CRO offering clinical trial services, FSP solutions, regulatory consulting, and post-market pharmacovigilance. Comparable full-lifecycle service breadth and a similar enterprise pharma/biotech target customer base.
• IQVIA: World's largest CRO and life sciences services provider, offering full-service clinical research, regulatory consulting, pharmacovigilance, real-world evidence, and technology solutions. Competes with ProPharma across nearly every service line, with far greater scale and breadth.
• Medpace: Publicly traded mid-sized CRO with strong therapeutic specialization in oncology, metabolic, cardiac, and rare diseases. Operates a full-service clinical CRO model that overlaps with ProPharma's CRO Services and FSP offerings.
• Parexel: Large CRO with particularly strong regulatory consulting and biopharmaceutical services, recently taken private. Direct competitor on regulatory sciences, clinical development, and pharmacovigilance engagements.
• Syneos Health: CRO with clinical and commercial services, recently taken private. Direct overlap on full-service clinical development, FSP, and post-marketing/medical information services targeting pharma and biotech clients.
• CTI Clinical Trial & Consulting Services: Mid-sized CRO with deep expertise in rare and orphan diseases, cell and gene therapies, and complex clinical research. Direct competitor for ProPharma on specialized therapeutic area CRO work and regulatory consulting for advanced therapies.
• PharmaLex (Cencora): Specialized regulatory, pharmacovigilance, and quality consulting firm now part of Cencora (formerly AmerisourceBergen). Most direct head-to-head competitor on regulatory sciences, QPPV, MAH partner, and pharmacovigilance service offerings.
• Worldwide Clinical Trials: Mid-sized global CRO focused on complex clinical trials in CNS, cardiometabolic, rare diseases, and oncology. Comparable mid-market positioning with full-service CRO, bioanalytical, and regulatory capabilities.
• Fortrea: CRO spun off from Labcorp Drug Development in 2023, offering clinical development, patient access, and post-approval services. Comparable full-service CRO portfolio targeting pharma and biotech sponsors globally.
• Charles River Laboratories: Global CRO and preclinical/early-stage research services provider with a strong Manufacturing Solutions and Research Models footprint. Comparable in serving pharma and biotech across the development lifecycle, though more weighted toward preclinical and manufacturing services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/southwood-research

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Southwood Research